Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

Abstract Immune checkpoint blockade‐related pneumonitis is a rare but potentially life‐threatening adverse effect, but its risk factors are not completely understood. This case‐control study was conducted to identify pneumonitis risk factors in patients treated with anti‐PD1 monoclonal antibodies (m...

Full description

Saved in:
Bibliographic Details
Main Authors: Pengfei Cui, Zhefeng Liu, Guoqiang Wang, Junxun Ma, Yuanyu Qian, Fan Zhang, Chun Han, Yaping Long, Ye Li, Xuan Zheng, Danyang Sun, Jing Zhang, Shangli Cai, Shunchang Jiao, Yi Hu
Format: Article
Language:English
Published: Wiley 2018-08-01
Series:Cancer Medicine
Subjects:
anti‐PD‐1
case‐control study
pneumonitis
risk factors
Online Access:https://doi.org/10.1002/cam4.1579
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items